Aniling Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Series A
- (Cancelled)
- Latest Deal Amount
-
$7.15M
- Investors
-
3
Aniling General Information
Description
Operator of a biotechnology company intended to accelerate epigenomics for precision medicine against cancer. The company aims to accelerate access to scientific advances in genomics and epigenomics by developing technologies with applicability as a prime requirement, enabling drug developers and pharma companies to develop better treatments for conditions such as cancer and genetic illnesses.
Contact Information
Website
www.aniling.comCorporate Office
- IGTP, Ctra Can Ruti
- Camí de les Escoles s/n
- 08916 Barcelona
- Spain
Corporate Office
- IGTP, Ctra Can Ruti
- Camí de les Escoles s/n
- 08916 Barcelona
- Spain
Aniling Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series A) | $7.15M | Cancelled | Generating Revenue | |||
| 6. Later Stage VC | 15-Dec-2021 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 31-Mar-2020 | Completed | Generating Revenue | |||
| 4. Grant | 01-Jun-2019 | Completed | Startup | |||
| 3. Accelerator/Incubator | 10-May-2019 | Completed | Startup | |||
| 2. Early Stage VC | 16-Oct-2018 | $742K | $1.01M | Completed | Startup | |
| 1. Early Stage VC | 17-Apr-2014 | $266K | $266K | Completed | Startup |
Aniling Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 12,063 | $1.129538 | $18.07 | $18.07 | 1x | $18.07 | 19.13% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Aniling Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Aniling Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Aniling Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| EIT Health | Accelerator/Incubator | |||
| CRAASH Barcelona | Accelerator/Incubator | |||
| BAGi | Angel Group | Minority |
Aniling FAQs
-
When was Aniling founded?
Aniling was founded in 2014.
-
Where is Aniling headquartered?
Aniling is headquartered in Barcelona, Spain.
-
What is the size of Aniling?
Aniling has 10 total employees.
-
What industry is Aniling in?
Aniling’s primary industry is Diagnostic Equipment.
-
Is Aniling a private or public company?
Aniling is a Private company.
-
What is Aniling’s current revenue?
The current revenue for Aniling is .
-
How much funding has Aniling raised over time?
Aniling has raised $4.95M.
-
Who are Aniling’s investors?
EIT Health, CRAASH Barcelona, and BAGi have invested in Aniling.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
